Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / NRBO - NeuroBo Pharmaceuticals rallies on ANA Therapeutics acquisition

NRBO - NeuroBo Pharmaceuticals rallies on ANA Therapeutics acquisition

NeuroBo Pharmaceuticals Inc.
NeuroBo Pharmaceuticals (NRBO) has acquired ANA Therapeutics, a biotechnology company developing ANA-001, currently in Phase 2/3 clinical trials as a treatment for COVID-19."This is an exciting and transformative acquisition for NeuroBo that expands our pipeline with a late-stage clinical development program that addresses the urgent need for new treatments to address COVID-19, a highly-infectious and often deadly virus," stated Richard J. Kang, Ph.D., President and CEO of NeuroBo.Terms of the transactions were not disclosed.NRBO +14.72% PM to $6.39.

For further details see:

NeuroBo Pharmaceuticals rallies on ANA Therapeutics acquisition
Stock Information
Company Name: NeuroBo Pharmaceuticals Inc.
Stock Symbol: NRBO
Market: NASDAQ
Website: neurobopharma.com
Menu
NRBO NRBO Quote NRBO Short NRBO News NRBO Articles NRBO Message Board
Get NRBO Alerts

News, Short Squeeze, Breakout and More Instantly...